Multiple pathogens and prostate cancer

Table 9 Mycoplasma infections and prostate cancer

Study	Country	Methods	Prostate cancer	Prostate non cancer controls	P value
Hrbacek 2011 M. hominis [88]	Czech Republic	Serology	60/330 18%	16/107 14%	0.518 ns
Hrbacek 2011 M. urealyticum [88]	Czech Republic	Serology	64/328 20%	11/105 11%	0.068 ns
Barykova 2011 M. hominis [123]	Russia US	Serology PCR	28/125 22% 5/27 19%	0/27 0% 4/31 13%	0.023 s
Urbanek 2011 M. hyorhinus [125]	US	Serology	59/114 52%	38/105 36%	0.279 ns
Erturhan 2013 [126]	Turkey	PCR	11/31 35%	0/31 0%	0.004 s
Yow 2014 M. genitalium [127]	Australia	PCR	9/115 8%	1/51 2%	0.163 ns
Miyake 2019 M. genitalium [128]	Japan	PCR	18/45 40%	6/33 18%	0.127 ns
Saadat 2020 M. Hominis [129]	Iran	PCR	8/61 13%	0/70 0%	0.003 s

ISSN: 1750-9378